Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, July 20, 2023.
Aetna’s policy update expanding access to Neuronetics NeuroStar represents a positive step towards increasing patient accessibility to innovative depression treatment options. Fast Five hosts Sean Whooley and Danielle Kirsh explain what NeuroStar is and the policy update that expands access to the technology.
Biostrap announced that it launched its new Kairos wearable device for data visualization of the autonomic nervous system. Such devices can potentially empower individuals to monitor their health metrics in real time. Hear how the technology works and what the company is doing for diagnostics for the nervous system.
Ascensia Diabetes Care’s deal to integrate blood glucose monitors in point-of-care testing reflects the importance of seamless data integration in diabetes management. Whooley details the partnership with Avricore Health and what kind of impact it will have on diabetes care delivery.
Teleflex’s completion of enrollment in a percutaneous coronary intervention study signifies progress in cardiovascular research. Find out more about the study and why it is important in treating coronary perforations in today’s episode.
Masimo’s adjustment of its 2023 healthcare sales guidance and cost-cutting efforts underscore the dynamic nature of the medical device industry.Whooley and Kirsh go over the reasons cited by Masimo for the potential reduction in sales guidance and analysts’ perspectives on the company’s challenges and its potential impact on the broader medtech industry.
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
Listen to previous episodes here.